Tech Center 1600 • Art Units: 1651 1657
This examiner grants 31% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17056446 | SPERM FERTILITY CAPACITY TEST AND SPERM DECAPACITATING SUPPLEMENT | Final Rejection | THE CURATORS OF THE UNIVERSITY OF MISSOURI |
| 19224021 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | Non-Final OA | WAGENINGEN UNIVERSITEIT |
| 17466516 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | Non-Final OA | WAGENINGEN UNIVERSITEIT |
| 18260914 | A METHOD TO IDENTIFY LVAD PATIENTS WITH ELEVATED LEVELS OF BLOOD ACTIVATION USING COUPON TESTS | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18220864 | COMBINATION THERAPEUTICS USING TUMOR TREATING FIELDS (TTFIELDS) | Non-Final OA | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
| 16310981 | Method and Composition for Reducing Pathogens in Rendered Food Products Using Lactic Acid Bacteria | Non-Final OA | Texas Tech University System |
| 18601536 | PROBIOTICS FOR COGNITIVE AND MENTAL HEALTH | Non-Final OA | INTERNATIONAL N&H DENMARK APS |
| 18520470 | HEMATOPOIETIC CELL PHENOTYPING USING CIRCULATING CELL-FREE MARKERS | Non-Final OA | Quest Diagnostics Investments LLC |
| 18070401 | FATTY LIVER AND LIVER FIBROSIS EVALUATION SYSTEM BASED ON IMPEDANCE | Non-Final OA | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY |
| 17431997 | NOVEL USES OF BOTULINUM NEUROTOXIN FOR THE TREATMENT OF TREMOR | Non-Final OA | Merz Pharma GmbH & Co. KGaA |
| 17789045 | LACTIC ACID BACTERIUM FERMENTATION PROMOTER | Final Rejection | MEIJI CO., LTD. |
| 18285088 | PROCESS FOR BIOCONJUGATE PRODUCTION | Non-Final OA | GLAXOSMITHKLINE BIOLOGICALS S.A. |
| 17907746 | METHOD FOR QUANTIFYING MODIFIED HDL AND ANALYTICAL REAGENT USED THEREFOR | Non-Final OA | Tatsuya Sawamura |
| 18240485 | SYSTEMS AND METHODS FOR PREDICTING RESPONSE TO ORAL MINOXIDIL FOR THE TREATMENT OF ANDROGENETIC ALOPECIA | Non-Final OA | Follea International |
| 17637128 | Cardiovascular Risk Event Prediction and Uses Thereof | Non-Final OA | SomaLogic Operating Co., Inc. |
| 18041606 | METHOD FOR DETERMINATION OF BASOPHIL ACTIVATION AND KITS THEREFORE | Non-Final OA | FORSCHUNGZENTRUM BORSTEL LEIBNIZ-LUNGENZENTRUM |
| 16245063 | SYSTEMS AND METHODS FOR ELECTROCHEMICAL CREATININE ASSAYS AND BLOOD UREA NITROGEN | Final Rejection | POLYMER TECHNOLOGY SYSTEMS, INC. |
| 17629603 | Astaxanthin Over-Producing Strains of Phaffia Rhodozyma | Non-Final OA | NextFerm Technologies Ltd. |
| 17606033 | FORMULATIONS AND METHODS FOR DRUG INSTILLATION INTO THE BLADDER AND TREATMENT OF BLADDER AILMENTS | Non-Final OA | TRIGONE PHARMA LTD. |
| 17427446 | T CELL REPERTOIRE DYNAMICS AND ONCOLYTIC VIRAL THERAPY | Non-Final OA | Oncolytics Biotech Inc. |
| 17310295 | LACTOCOCCUS LACTIS STRAINS FOR THE PREVENTION AND/OR THE TREATMENT OF VISCERAL PAIN | Final Rejection | Universite Toulouse III - Paul Sabatier |
| 17282667 | ARTIFICIAL HUMAN PULMONARY AIRWAY AND METHODS OF PREPARATION | Non-Final OA | Andrei GEORGESCU |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy